CERo Therapeutics Holdings, Inc., (Nasdaq: CERO) (“CERo” or the “Company”) an innovative immunotherapy company seeking to ...
The move is part of the company’s plan to issue $21 billion of equity and $21 billion in fixed-income instruments over the next three years.
MicroStrategy Inc. unveiled its latest capital raise late Friday with news of plans to issue $2 billion in preferred stock to raise the funds needed to buy more bitcoin. The business-software company ...